This K05 grant will provide training, educational, and research experiences that allow Dr. Timothy Baker to perform groundbreaking research, both transdisciplinary and translational, on tobacco use and other addictive disorders. Specifically, the research will foster the integration of theories, data, and methods from diverse disciplines and among many collaborators. In addition, it will permit him to conduct translational research in which innovative basic science models and methods are used to generate new treatments and assessments;viz. to facilitate the transfer of basic science findings and perspectives so that they achieve more effective real-world application. The requested support also will facilitate Dr. Baker's teaching and training of the future cadre of addiction scientists, especially in providing clinical science training that emphasizes transdisciplinary research strategies with clear potential for application. To accomplish these aims, the applicant will: (1) use the requested support to reduce his administrative and teaching obligations;(2) take classes, engage in intensive reading and study, and consult with experts in targeted areas of special relevance to the applicant's research;(3) design and conduct new research studies that provide outstanding opportunity for transdisciplinary and translational research addressing tobacco use and other addictive disorders;and, (4) train new tobacco scientists. This training of new scientists will be accomplished via mentoring activities with graduate and post-doctoral students, additional didactic instruction, and intensive workshops offered to junior scientists recruited nationally. The proposed work will benefit from the tremendous resources available in the applicant's research environment and by his on-going research with a large transdisciplinary team. This K05 grant should benefit public health by enhancing the quality of research on addictive disorders performed by Dr. Baker, his collaborators, and those he trains. Specifically, this support should promote better understanding of tobacco use and other addictive disorders and, ultimately, impact the health of the nation by producing more effective treatments for these devastating diseases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Scientist Award (K05)
Project #
5K05CA139871-05
Application #
8324683
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Perkins, Susan N
Project Start
2008-09-19
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2012
Total Cost
$170,073
Indirect Cost
$12,598
Name
University of Wisconsin Madison
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Bold, Krysten W; Rasheed, Abdullah S; McCarthy, Danielle E et al. (2015) Rates and predictors of renewed quitting after relapse during a one-year follow-up among primary care patients. Ann Behav Med 49:128-40
Bloom, A Joseph; Baker, Timothy B; Chen, Li-Shiun et al. (2014) Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms. Hum Mol Genet 23:555-61
Stein, James H; Asthana, Asha; Smith, Stevens S et al. (2014) Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: three-year outcomes after a quit attempt. PLoS One 9:e98278
Smith, Stevens S; Fiore, Michael C; Baker, Timothy B (2014) Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction 109:2107-17
Gennuso, Keith P; Thraen-Borowski, Keith M; Schlam, Tanya R et al. (2014) Smokers' physical activity and weight gain one year after a successful versus unsuccessful quit attempt. Prev Med 67:189-92
Leventhal, Adam M; Piper, Megan E; Japuntich, Sandra J et al. (2014) Anhedonia, depressed mood, and smoking cessation outcome. J Consult Clin Psychol 82:122-9
Chen, Li-Shiun; Baker, Timothy B; Piper, Megan E et al. (2014) Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction. Drug Alcohol Depend 143:36-43
Bloom, A Joseph; Hartz, Sarah M; Baker, Timothy B et al. (2014) Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. Ann Am Thorac Soc 11:1003-10
Chen, Li-Shiun; Bloom, A Joseph; Baker, Timothy B et al. (2014) Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Addiction 109:128-37
Smith, Stevens S; Keller, Paula A; Kobinsky, Kate H et al. (2013) Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant. Nicotine Tob Res 15:718-28

Showing the most recent 10 out of 38 publications